Teixeira et al. show that cyclin E deregulation causes cells to enter into mitosis with incompletely replicated genomes, leading to chromosome segregation anomalies and copy number losses originating at specific unreplicated loci. Their study demonstrates how oncogene-induced replication stress contributes to genomic instability in human cancer.
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In Brief
Teixeira et al. show that cyclin E deregulation causes cells to enter into mitosis with incompletely replicated genomes, leading to chromosome segregation anomalies and copy number losses originating at specific unreplicated loci. Their study demonstrates how oncogene-induced replication stress contributes to genomic instability in human cancer.
SUMMARY
Cell-cycle progression is regulated by the cyclindependent kinase (Cdk) family of protein kinases, so named because their activation depends on association with regulatory subunits known as cyclins [1] . Cyclin E normally accumulates at the G1/S boundary, where it promotes S phase entry and progression by activating Cdk2. In normal cells, cyclin E/Cdk2 activity is associated with DNA replication-related functions [2] . However, deregulation of cyclin E leads to inefficient assembly of pre-replication complexes [3] , replication stress [4] , and chromosome instability [5] . In malignant cells, cyclin E is frequently overexpressed, correlating with decreased survival in breast cancer patients [6, 7] . Transgenic mice deregulated for cyclin E in the mammary epithelia develop carcinoma [8] , confirming that cyclin E is an oncoprotein. However, it remains unknown how cyclin E-mediated replication stress promotes genomic instability during carcinogenesis. Here, we show that deregulation of cyclin E causes human mammary epithelial cells to enter into mitosis with short unreplicated genomic segments at a small number of specific loci, leading to anaphase anomalies and ultimately deletions. Incompletely replicated regions are preferentially located at late-replicating domains, fragile sites, and breakpoints, including the mixed-lineage leukemia breakpoint cluster region (MLL BCR). Furthermore, these regions are characterized by a paucity of replication origins or unusual DNA structures. Analysis of a large set of breast tumors shows a significant correlation between cyclin E amplification and deletions at a number of the genomic loci identified in our study. Our results demonstrate how oncogene-induced replication stress contributes to genomic instability in human cancer.
RESULTS

Ongoing DNA Replication in Mitotic Cells
Cyclin E-mediated replication stress results in depressed origin firing [9] , slowed fork progression [10] , and aberrant fork architecture [11] . However, the molecular mechanisms that link replication stress to genomic instability remain poorly understood. We hypothesized that cyclin E deregulation expands the time interval required for DNA replication, causing cells to enter into mitosis with incompletely replicated genomes. To test this idea, we used recombinant cyclin E-expressing adenoviruses to increase cyclin E levels in immortalized human mammary epithelial cells (HME1) ( Figure 1A ). MDA-MB-157 [12] and SUM149PT [13] , breast cancer-derived cell lines that overexpress cyclin E, were used as controls. Transduction multiplicities that recapitulated cyclin E levels observed in the high cyclin E breast cancer cell lines ( Figure 1A ) were used in all subsequent experiments. To compare the rate of S phase progression in cells deregulated for cyclin E expression and controls, we transduced HME1 cells with cyclin E and control viruses and released from a double-thymidine block for 8 hr ( Figure 1B ). Flow cytometric analysis revealed that cyclin E deregulation reduced the rate of progression through S phase (control = 20% versus cyclin E = 62% remaining in S phase after 8 hr). Cells expressing deregulated cyclin E required $12-16 hr to complete S phase (Figure S1A ). To determine whether cells could enter into mitosis with ongoing replication, we used strong phosphorylation of histone H3 on serine 10 as a marker for late G2/M phase, while ongoing replication was scored by incorporation of BrdU during a short pulse (Figures S1B and S1C). A significant fraction of cyclin E-deregulated cells that stained strongly positive for phospho-H3 also stained positive for BrdU incorporation (cyclin E = 16.4%, n = 286; Figures 1C and 1D ). However, doublepositive cells were completely absent in controls (n = 526; Figure 1D) . Increased transduction multiplicities correlated with higher frequencies of double-positive cells, reaching almost 50% of the total ( Figure 1E ). These data indicate that a fraction of cells experiencing cyclin E deregulation are near or in mitosis while DNA replication is ongoing. therefore screened cyclin E-deregulated HME1 cells for aberrant mitotic chromosome dynamics by live-cell microscopy (Figure 2A) . Cyclin E deregulation caused a 3.2-fold increase in abnormal metaphase-to-telophase transitions (control = 16.3% versus cyclin E = 53.2%; n > 100, p = 2.9 3 10 À5 , unpaired t test; Figure 2B ), including the formation of anaphase bridges, lagging chromosomes, and micronuclei (AB, p = 0.0037; LC, p = 0.0009; MN, p = 0.0025, unpaired t test; Figure S2A ; Movies S1 and S2). These abnormal anaphases are consistent with attempted chromosome segregation in the presence of incompletely replicated DNA [14] [15] [16] .
Cyclin E Causes Replication Failure at a Limited Number of Specific Genomic Loci To determine whether specific loci are incompletely replicated in mitotic cells after one cell cycle during which cyclin E was deregulated, we carried out comparative genome hybridization (CGH) array analysis on DNA from prometaphase cells that were first synchronized by a double-thymidine block and released into nocodazole (see Supplemental Experimental Procedures). CGH arrays indicated $20-fold more underreplicated chromosomal segments than overreplicated segments upon cyclin E deregulation (8,334 versus 341 probes in at least one sample; Figure S3A and Table S1 ). We then focused on chromosomal segments that were scored as underreplicated in at least two of the three experiments and were detected by at least five contiguous probes. Surprisingly, decreased signals, indicating underreplication, were concentrated at only 16 genomic loci distributed over many chromosomes and varied in size from a few kb to over 100 kb (Table 1 and Figure S3B ). These loci were frequently, but not always, located in late-replicating domains based on replication timing of IMR-90 human fibroblasts (Table 1 ) [17] . Furthermore, some loci were located in pericentromeric or subtelomeric regions, as well as fragile sites and breakpoint or recombination hotspots (Table 1 ) [18] . Note that one of the sites encompasses the breakpoint cluster region of the mixed-lineage leukemia gene (mixed-lineage leukemia breakpoint cluster region [MLL BCR]; Table 1 and Table S1 ), often rearranged in leukemias [19] but also deleted in breast cancer (see below).
To determine whether underreplication after one pulse of cyclin E correlates with eventual genomic loss in proliferating populations, we transduced HME1 cells twice a week for 3 weeks with control or cyclin E adenovirus, after which average copy number at eight loci that exhibited underreplication in the population was interrogated by real-time PCR ( Figure 2C ). Significant genomic losses were detected for six of the eight loci analyzed, with signal decreases varying from 12% to 17%, confirming a link between cyclin E-mediated underreplication and subsequent genomic loss. For a heterogeneous diploid cell population, a signal decrease of 15% indicates that one in every three cells has experienced a deletion at the interrogated locus.
To determine the frequency of cells experiencing genomic losses at specific loci, we analyzed single cells for deletion at three loci by real-time PCR. HME1 cells were transduced twice with control or cyclin E adenovirus, and individual cells were isolated by fluorescence-activated cell sorting (FACS). Genomes from eight control and nine cyclin E cells were amplified and analyzed for deletions at loci 2, 3, and 14 ( Figures 2D-2F ). Deletions were detected in one of the nine cyclin E cells at locus 2 (cell E1, Figure 2D) and two of the nine cyclin E cells at loci 3 and 14, respectively (cells E7 and E8, Figure 2E ; cells E2 and E8, Figure 2F ). The occurrence of five deletions at three loci for nine cyclin E cells compared to none for eight control cells was significant (p = 0.032, Fisher's exact test).
Cyclin E Deregulation Causes Loss of the MLL BCR Locus
We then specifically addressed deletion at the MLL BCR locus by fluorescence in situ hybridization (FISH) ( Figure 2G ). Cyclin E deregulation caused an almost 3-fold increase in aberrant FISH signals at this locus (control = 1.77% versus cyclin E = 5.11%; n > 5,000 cells, p = 0.0104, unpaired t test; Figure 2H ). The primary signal differences observed were loss of the distal region (1R/2G = loss of one red signal; control = 0.153% versus cyclin E = 1.147%, p = 0.0040, unpaired t test; Figure 2I ) and the loss of one entire copy of the locus through micronucleus formation (MN, control = 0.034% versus cyclin E = 0.269%, p = 0.0231, unpaired t test; Figure 2I ). These data are consistent with persistence of unreplicated DNA during mitosis, leading to chromosome breaks and subsequent loss of genetic material [14] [15] [16] .
Consistent with this, a recent study showed that cyclin E deregulation frequently causes deletion of most or all of the right arm of chromosome 3 [20] , which contains several of the loci identified in this study.
Origin Paucity Correlates with Genomic Loss
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fork collapse [21] , and which also reduces the likelihood of rescue by adjacent forks [22] . We therefore addressed DNA replication origin (ORI) density at the 16 genomic loci found underreplicated in CGH experiments using two databases of human genome-wide origin distribution [23, 24] (Figures 3A and  S2B ). It is noteworthy that ORI mapping data in mammalian cells have been characterized by low reproducibility. However, analysis of a 1-Mb region surrounding each locus showed that many of the loci are located in origin-poor regions (locus # 2, 3, 4, 7, 9-15; Figure 3A) , and the total number of ORIs in the 1-Mb neighborhoods surrounding the 16 genomic loci is significantly lower than the total number of ORIs in the 1-Mb neighborhoods of 16 randomly selected genomic locations (94 versus 161 ORIs [23] ; p < 0.025, permutation-based enrichment test; Table S2 ). Remarkably, among the 16 genomic loci, seven are located R400 kb away from the closest ORI, including four loci that are more than 600 kb from the closest ORI (locus # 3, 11, 12, and 14; Table S2 ). In comparison, only 3 out of 16 randomly selected genomic loci are located R400 kb away from the closest ORI [23] . Although these data are only correlative and not derived from HME1 cells, they suggest that paucity of replication origins may contribute to the replication impairment and eventual loss of specific regions in response to cyclin E deregulation.
Unusual DNA Structures Can Contribute to Cyclin E-Mediated Genomic Loss
Another feature of regions that are sensitive to replication stress is DNA sequences that are predicted to form stem-loops [25] . The MLL BCR, identified in our study, is not in an origin-poor or late-replicating region. However, analysis of DNA folding of the MLL BCR N terminus, underreplicated in our CGH experiments, showed two putative stem-loop structures located in introns 7 and 8: DG = À7.15 kcal and À9.69 kcal, respectively ( Figures S2C and S2D ). The stem-loop structures consist of 94 bp and 67 bp, respectively, and are separated by approximately 500 bp. To test the idea that cyclin E deregulation promotes deletions by impairing replication of such structures, we cloned part of the MLL BCR N terminus containing the two stem-loop structures into the episomal plasmid pCEP4 (Figure 3B ; see Supplemental Experimental Procedures). As a control, the same sequence missing the stem-loops was inserted into the vector. Cyclin E deregulation had no effect on the control plasmid but conferred a dose-dependent impairment of maintenance and transmission of the plasmid containing the two stem-loop-forming structures, as measured by relative number of hygromycin-resistant cells (low cyclin E, p = 0.012; high cyclin E, p = 9.7 3 10 À5 , unpaired t test; Figures 3C, S2E , and S2F) or by relative replicated plasmid levels, as determined by real-time PCR (p = 0.0019, unpaired t test; Figures 3D, S2G , and S2H).
Cyclin E Amplification Correlates with Loss of Specific Genomic Regions in Breast Cancer
We next evaluated the relevance of our in vitro findings to breast cancer. CGH arrays from 1,962 primary fresh-frozen breast cancer specimens [18] were interrogated for association between cyclin E1 amplification and copy number losses at the genomic regions established in vitro by CGH (see Supplemental Experimental Procedures). We observed a significant correlation between cyclin E1 gain and genomic region loss in 6 out of 16 analyzed loci (locus # 2, 3, 4, 11, 12, 14; p < 0.05, Fisher's exact test; Figure S3C ). Furthermore, three additional loci (locus # 6, 7, 16; Figure S3C ), including the N terminus of the MLL BCR Figure S3 and Table S1 .
locus, were lost in more than 10% of breast cancer patients (locus # 6 = 16.6%, n = 326 out of 1,962 [copy number variation [CNV] patients per all patients]), even though these losses did not correlate with cyclin E1 amplification ( Figure S3C ). It is therefore likely that other mechanisms contribute to copy number losses at these genomic loci, masking the effects of cyclin E1 overexpression. Taken together, our data show that cyclin E deregulation causes cells to enter into mitosis with incompletely replicated genomes, leading to chromosome segregation anomalies and copy number losses originating at specific unreplicated loci and thus contributing to the genomic instability observed in breast cancer.
DISCUSSION
Oncogene expression has been linked to replication stress, leading to stalled replication forks, DNA damage, and, ultimately, impaired progression through S phase [4, [26] [27] [28] [29] [30] . It has been assumed that a cell-cycle checkpoint prevents cells with expanded replication times from entering mitosis prior to completion of DNA replication. However, in the case of cyclin E deregulation, cells are not prevented from entering mitosis with a small number of short unreplicated segments. These data suggest that a minimal amount of unreplicated DNA is required to trigger this checkpoint and that levels below a threshold can evade surveillance [14, 31] .
It is not clear why a small select group of loci are particularly sensitive to cyclin E-mediated replication failure. Nevertheless, these loci appear to subdivide into two classes, suggesting that at least two different mechanisms may be involved. The first class, which includes most of the loci identified, is characterized by location within late-replicating domains with a paucity of replication origins. This suggests a mechanism whereby fork collapse caused by cyclin E-mediated replication stress cannot be repaired prior to mitotic entry because of late timing of origin initiation and large inter-origin distances prohibiting rescue by adjacent forks [32, 33] . However, not all origin-poor late-replicating regions were identified in our study. It is therefore likely that other properties of these regions contribute to their sensitivity to cyclin E deregulation. One possible compounding factor may be related to the observation that cyclin E overexpression interferes with pre-replication complex assembly [3] , exacerbating replication stress by preventing the formation of dormant origins required to rescue collapsed forks [22] . Thus, it may be that the cyclin E-sensitive loci identified in this study are particularly impaired in formation of dormant origins when cyclin E is overexpressed.
The second class of loci, typified by the MLL BCR, might be characterized by structured DNA that is likely to impose a barrier to replication fork progression. The likely mechanism of replication failure is that cyclin E-mediated replication stress sensitizes forks so that they tend to stall or collapse when they encounter 0.0e+00 5.0e+07 1.0e+08 1.5e+08 2.0e+08 ). See also Figure S2 and Table S2. such structures. However, many such structures have been identified in the genome [32, 34] . Yet, most of these were not identified as cyclin E sensitive in the current study. Again, other factors must contribute to sensitization by cyclin E overexpression. One possible explanation is that the MLL BCR contains two predicted stem-loops within a short distance (500 bp). Interestingly, one well-defined MLL breakpoint in intron 8 localizes at the base of the putative stem-loop structure identified here, which also contains a binding site for topoisomerase II and recombinase [35] . On the other hand, deletion of the MLL BCR in breast cancer, which is quite frequent, did not correlate with cyclin E amplification, suggesting that stem-loop structures are sensitive to multiple forms of replication stress. Nevertheless, a study of MLL rearrangements in leukemia patients identified elevated cyclin E levels as a major driver [36] , indicating that in some cancers, cyclin E-mediated replication stress is critical for damage at this locus.
Our findings suggest a mechanism for how replication stress contributes to genomic instability in cancer. In particular, we demonstrate a likely mechanism to explain specific genetic losses that occur during mammary tumorigenesis mediated by cyclin E deregulation. It will be interesting to determine whether the same mechanisms apply in other cell types and cancers driven by cyclin E, as well as other oncoproteins. 
